Artemether Attenuates LPS-induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis and Bone Resorption via Suppression of MAPK Signaling Pathway

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-0540-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1

Frontiers in Pharmacology
Pharmacology
2020English

Achyranthes Bidentata Polysaccharide Suppresses Osteoclastogenesis and Bone Resorption via Inhibiting RANKL Signaling

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2018English

Dihydroartemisinin Attenuates Lipopolysaccharide-Induced Osteoclastogenesis and Bone Loss via the Mitochondria-Dependent Apoptosis Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

Fangchinoline Protects Against Bone Loss in OVX Mice via Inhibiting Osteoclast Formation, Bone Resorption and RANKL-induced Signaling

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption

Frontiers in Pharmacology
Pharmacology
2017English

Genistein Prevents Bone Resorption Diseases by Inhibiting Bone Resorption and Stimulating Bone Formation

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2003English

Bone Resorption in Syndromes of the Ras/Mapk Pathway

Clinical Genetics
Genetics
2011English

IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy